A2A adenosine receptor antagonists: are triazolotriazine and purine scaffolds interchangeable?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Molecules (2022) 27:8, 2386. https://doi.org/10.3390/molecules27082386
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2023
- Urheber
-
Spinaci, Andrea
Lambertucci, Catia
Buccioni, Michela
Dal Ben, Diego
Graiff, Claudia
Barbalace, Maria Cristina
Hrelia, Silvana
Angeloni, Cristina
Tayebati, Seyed Khosrow
Ubaldi, Massimo
Masi, Alessio
Klotz, Karl-Norbert
Volpini, Rosaria
Marucci, Gabriella
- DOI
-
10.3390/molecules27082386
- URN
-
urn:nbn:de:bvb:20-opus-270618
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Spinaci, Andrea
- Lambertucci, Catia
- Buccioni, Michela
- Dal Ben, Diego
- Graiff, Claudia
- Barbalace, Maria Cristina
- Hrelia, Silvana
- Angeloni, Cristina
- Tayebati, Seyed Khosrow
- Ubaldi, Massimo
- Masi, Alessio
- Klotz, Karl-Norbert
- Volpini, Rosaria
- Marucci, Gabriella
- Universität Würzburg
Entstanden
- 2023
Ähnliche Objekte (12)
Irreversible Antagonists for the Adenosine A2B Receptor
Barbiturates are selective antagonists at A1 adenosine receptors
8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors
Adenosine 2a receptor signaling in autoimmune neuroinflammation
Adenosine receptor agonists: Synthesis and biological evaluation of 1-deaza analogues of adenosine
In vivo pharmacological profiling in Xenopus embryos defines a subset of A1 adenosine receptor-selective antagonists with potent anti-angiogenic activities
Multivalently binding antagonists for the neurokinin-1 receptor
Mechanism of A2 adenosine receptor activation. I. Blockade of A2 adenosine receptors by photoaffinity labeling
Histamine H3 receptor antagonists in combination with monoamine oxidase B and adenosine A1/A2A receptor ligands as multi-target approach for the treatment of Parkinson´s disease
Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
The effects of beta receptor antagonists on the myorcardium
Irreversible Antagonists for the Adenosine A2B Receptor
Barbiturates are selective antagonists at A1 adenosine receptors
8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors
Adenosine 2a receptor signaling in autoimmune neuroinflammation
Adenosine receptor agonists: Synthesis and biological evaluation of 1-deaza analogues of adenosine
In vivo pharmacological profiling in Xenopus embryos defines a subset of A1 adenosine receptor-selective antagonists with potent anti-angiogenic activities
Multivalently binding antagonists for the neurokinin-1 receptor
Mechanism of A2 adenosine receptor activation. I. Blockade of A2 adenosine receptors by photoaffinity labeling
Histamine H3 receptor antagonists in combination with monoamine oxidase B and adenosine A1/A2A receptor ligands as multi-target approach for the treatment of Parkinson´s disease
Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists
Structure-Based Development of Selective Orexin 1 Receptor Antagonists
The effects of beta receptor antagonists on the myorcardium
Irreversible Antagonists for the Adenosine A2B Receptor
Barbiturates are selective antagonists at A1 adenosine receptors
8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors
Adenosine 2a receptor signaling in autoimmune neuroinflammation
Adenosine receptor agonists: Synthesis and biological evaluation of 1-deaza analogues of adenosine
In vivo pharmacological profiling in Xenopus embryos defines a subset of A1 adenosine receptor-selective antagonists with potent anti-angiogenic activities
Multivalently binding antagonists for the neurokinin-1 receptor
Mechanism of A2 adenosine receptor activation. I. Blockade of A2 adenosine receptors by photoaffinity labeling
Histamine H3 receptor antagonists in combination with monoamine oxidase B and adenosine A1/A2A receptor ligands as multi-target approach for the treatment of Parkinson´s disease
Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists
Structure-Based Development of Selective Orexin 1 Receptor Antagonists